{"id":2020,"date":"2020-05-20T20:37:02","date_gmt":"2020-05-20T20:37:02","guid":{"rendered":"https:\/\/mirm-pitt.net\/technologies\/?post_type=avada_portfolio&p=2020"},"modified":"2020-07-08T07:30:24","modified_gmt":"2020-07-08T07:30:24","slug":"targeted-delivery-of-glycine-receptors-to-excitable-cells-2","status":"publish","type":"avada_portfolio","link":"https:\/\/mirm-pitt.net\/technologies\/patents\/targeted-delivery-of-glycine-receptors-to-excitable-cells-2\/","title":{"rendered":"Targeted Delivery Of Glycine Receptors To Excitable Cells (2)"},"content":{"rendered":"

Targeted Delivery Of Glycine Receptors To Excitable Cells (2)<\/h2>\n

Focused On A Replication-Defective HSV Vector Comprising An Expression Cassette Encoding A Glyr Protein<\/p>\n<\/div>

<\/div><\/div><\/div>

Inventors:<\/strong> Michael Cascio: Joseph C. Glorioso III: James R. Goss: David M. Krisky M.D., Ph.D.<\/p>\n

Patent Number:<\/strong> 14\/584,895<\/p>\n

\n
\n
\n

Abstract<\/h3>\n
\n
\n
The invention provides a method of modulating electrophysiological activity of an excitable cell. The method involves causing exogenous expression of a glycine receptor (GlyR) protein in an excitable cell of a subject. Thereafter, the excitable cell is exposed to an allosteric modulator of the GlyR protein. Modulation of the exogenous GlyR protein (an ion channel) in response to the allosteric modulator modulates the electrophy-stological activity of the excitable cell. The method can be used to control pain in a subject. The invention further provides a replication-defective HSV vector comprising an expression cassette encoding a GlyR protein, stocks and pharmaceutical compositions containing such vectors, and a transgenic animal.<\/div>\n<\/section>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>
<\/div>
<\/div>
<\/div>